Search
for

    Sort by

    Research 631–660 of 1000+

    1. Successful in situ 5-aminolevulinic acid photodynamic therapy in a 53-year-old female with cutaneous squamous cell carcinoma Journal of Zhejiang University SCIENCE B · 2025 · 1 citations
    2. Integrated edge information and pathway topology for drug-disease associations iScience · 2024
    3. 5alpha-reductase inhibitors/finasteride. PubMed · 1996 · 4 citations
    4. Adherence with protocol medication use and mortality from unrelated causes in a prevention trial Preventive Medicine · 2021 · 1 citations
    5. Sometimes Marketing Efforts by Advocacy Organizations Can Lose Touch with the Nuances of Appropriateness Oncology Times · 2004
    6. Targeting of Smoothened for therapeutic gain Trends in Pharmacological Sciences · 2014 · 105 citations
    7. Finasteride Drugs · 1993 · 86 citations
    8. Biomarker-based methods for determining noncompliance in a prevention trial Controlled Clinical Trials · 2002 · 11 citations
    9. Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats Research and reports in urology · 2022 · 6 citations
    10. IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study Urology · 2023 · 2 citations
    11. This Week in JAMA JAMA · 2009
    12. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects Frontiers in Endocrinology · 2021 · 59 citations
    13. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges Frontiers in Immunology · 2022 · 44 citations
    14. Cannabis sativa IGI Global eBooks · 2023
    15. The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship Dermatology Online Journal · 2009
    16. Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia Internal Medicine Journal · 2024 · 9 citations
    17. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) The Aging Male · 2026
    18. Dermatological care of gender‐diverse patients in Australia Australasian Journal of Dermatology · 2024
    19. Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies Cancers · 2023
    20. Androgens’ Effects across the Lifespan in Men and Animal Models IntechOpen eBooks · 2021
    21. Going Beyond Hair: Seven Simple Actions We Can Take to Help Prevent Major Illness in Our Hair Transplant Patients Hair transplant forum international · 2014
    22. Actinic keratosis: a clinical and epidemiological revision Anais Brasileiros de Dermatologia · 2012 · 89 citations
    23. The molecular pathogenesis of Trichilemmal carcinoma BMC Cancer · 2020 · 19 citations
    24. Role of ACE2 polymorphism in COVID-19: impact of age Clinical Chemistry and Laboratory Medicine · 2021 · 6 citations
    25. The significance of the apelinergic system in doxorubicin-induced cardiotoxicity Heart Failure Reviews · 2024 · 13 citations
    26. Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital Anais Brasileiros de Dermatologia · 2021 · 7 citations
    27. Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India Indian Journal of Endocrinology and Metabolism · 2025
    28. Hiperplasia quística prostática en un perro joven: reporte de caso MQRInvestigar · 2023
    29. Hair Growth Promoting and Anticancer Effects of p21-activated kinase 1 (PAK1) Inhibitors Isolated from Different Parts of Alpinia zerumbet Molecules · 2017 · 13 citations
    30. Intracrine androgen biosynthesis, metabolism and action revisited Molecular and Cellular Endocrinology · 2017 · 131 citations